TABLE 1.
Drugs Approved by the US Food and Drug Administration With Academic Patents: 1988–2005
| NDA No. | Tradename (Ingredient) | Approval Year | Public Sector Patent Holder |
| 20 212 | Zinecard (dexrazoxane hydrochloride)a | 1995 | New York University |
| 20 412 | Zerit (stavudine)a | 1994 | Yale University |
| 20 413 | Zerit (stavudine) | 1996 | Yale University |
| 21 453 | Zerit XR (stavudine) | 2002 | Yale University |
| 20 819 | Zemplar (paricalcitol)b | 1998 | University of Wisconsin |
| 21 606 | Zemplar (paricalcitol) | 2005 | University of Wisconsin |
| 21 636 | Zegerid (omeprazole; sodium bicarbonate) | 2004 | University of Missouri |
| 21 706 | Zegerid (omeprazole; sodium bicarbonate) | 2004 | University of Missouri |
| 20 597 | Xalatan (latanoprost)a | 1996 | Columbia University |
| 20 961 | Vitravene Preservative Free (fomivirsen sodium)a | 1998 | US Government, HHS |
| 20 569 | Vitrasert (ganciclovir) | 1996 | University of Kentucky |
| 21 119 | Visudyne (verteporfin)a | 2000 | Massachusetts General Hospital |
| 20 154 | Videx (didanosine)a | 1991 | US Government, HHS |
| 20 155 | Videx (didanosine) | 1991 | US Government, HHS |
| 20 156 | Videx (didanosine) | 1991 | US Government, HHS |
| 21 183 | Videx ec (didanosine) | 2000 | US Government, HHS |
| 21 267 | Vfend (voriconazole) | 2002 | University of Kansas |
| 21 602 | Velcade (bortezomib)a | 2003 | US Government, HHS |
| 19 981 | Ultratag (technetium TC-99M red blood cell kit) | 1991 | Associated Universities Inc. |
| 21 752 | Truvada (emtricitabine; tenofovir disoproxil fumarate) | 2004 | Emory University |
| 20 408 | Trusopt (dorzolamide hydrochloride)a | 1994 | University of Florida |
| 21 248 | Trisenox (arsenic trioxide)a | 2000 | Sloan-Kettering |
| 20 505 | Topamax (topiramate)b | 1996 | New England Medical Center |
| 20 844 | Topamax Sprinkle (topiramate) | 1998 | New England Medical Center |
| 20 898 | Thyrogen (thyrotropin alfa)a | 1998 | Sloan-Kettering |
| 20 785 | Thalomid (thalidomide)a | 1998 | Children's Hospital Boston |
| 20 262 | Taxol (paclitaxel)a | 1992 | US Government, HHS |
| 21 055 | Targretin (bexarotene)a | 1999 | SRI International |
| 19 836 | Supprelin (histrelin acetate)a | 1991 | Salk Institute |
| 19 890 | Stadol (butorphanol tartrate) | 1991 | University of Kentucky |
| 20 657 | Sporanox (itraconazole) | 1997 | US Government, HHS |
| 21 106 | Somavert (pegvisomant)a | 2003 | Ohio University |
| 19 608 | Sildaflo (silver sulfadiazine) | 1989 | Research Corporation |
| 21 544 | Seasonale (ethinyl estradiol; levonorgestrel) | 2003 | Medical College of Hampton Roads |
| 21 320 | Plenaxis (abarelix)a | 2003 | Indiana University |
| 20 958 | Pepcid Complete (calcium carbonate; famotidine; magnesium hydroxide) | 2000 | Brigham and Women's Hospital |
| 19 880 | Paraplatin (carboplatin)a | 1989 | Research Corporation (on behalf of Michigan State University) |
| 20 886 | Panretin (alitretinoin)a | 1999 | Salk Institute |
| 19 927 | Nizoral (ketoconazole) | 1990 | University of Tennessee |
| 20 310 | Nizoral A-D (ketoconazole) | 1997 | University of Tennessee |
| 20 326 | Neutrexin (trimetrexate glucuronate)a | 1993 | US Government, HHS |
| 21 487 | Namenda (memantine hydrochloride)b | 2003 | Children's Hospital Boston |
| 20 586 | Meretek UBT kit (with pranactin) (urea, C-13)b | 1996 | Baylor College of Medicine |
| 21 674 | Menostar (estradiol) | 2004 | University of California |
| 21 446 | Lyrica (pregabalin)a | 2004 | Northwestern University |
| 20 845 | Inomax (nitric oxide)a | 1999 | Massachusetts General Hospital |
| 20 199 | Hivid (zalcitabine)a | 1992 | US Government, HHS |
| 20 076 | Habitrol (nicotine) | 1991 | University of California |
| 20 637 | Gliadel (carmustine) | 1996 | Massachusetts Institute of Technology |
| 19 863 | Geref (sermorelin acetate)b | 1990 | Salk Institute |
| 20 443 | Geref (sermorelin acetate) | 1997 | Salk Institute |
| 21 481 | Fuzeon (enfuvirtide)a | 2003 | Duke University |
| 20 038 | Fludara (fludarabine phosphate)a | 1991 | US Government, HHS |
| 20 195 | Fentanyl (fentanyl citrate) | 1993 | University of Utah |
| 20 044 | Exosurf neonatal (cetyl alcohol; colfosceril palmitate; tyloxapol)a | 1990 | University of California |
| 19 677 | Enlon-plus (atropine sulfate; edrophonium chloride) | 1991 | University of California |
| 21 500 | Emtriva (emtricitabine)b | 2003 | Emory University |
| 21 896 | Emtriva (emtricitabine) | 2005 | Emory University |
| 20 193 | Elmiron (pentosan polysulfate sodium)b | 1996 | University of California |
| 21 283 | Diovan (valsartan) | 2001 | Brigham and Women's Hospital |
| 20 869 | Cosopt (dorzolamide hydrochloride; timolol maleate) | 1998 | University of Florida |
| 21 673 | Clolar (clofarabine)a | 2004 | Southern Research Institute |
| 21 197 | Cetrotide (cetrorelix)b | 2000 | Tulane University |
| 19 829 | Ceretec (technetium TC-99M exametazime kit)a | 1988 | University of Missouri |
| 19 785 | Cardiolite (technetium TC-99M sestamibi kit)b | 1990 | Harvard College |
| 20 954 | Busulfex (busulfan) | 1999 | University of Texas |
| 20 404 | Avita (tretinoin) | 1997 | University of California |
| 21 316 | Altoprev (lovastatin) | 2002 | Children's Hospital Boston |
| 21 462 | Alimta (pemetrexed disodium)a | 2004 | Princeton University |
| 19 937 | Adenocard (adenosine)a | 1989 | University of Virginia |
| 20 747 | Actiq (fentanyl citrate) | 1998 | University of Utah |
| 20 162 | Acthrel (corticorelin ovine triflutate)a | 1996 | Salk Institute |
Note. HHS = US Department of Health and Human Services; NDA = new drug application.
New molecular entity that received priority approval.
New molecular entities that did not receive priority approval.